SpyBiotech, a biotechnology company with a vaccine platform technology targeting infectious diseases, cancer and chronic diseases, has appointed Simon Jones as VP of Finance and Operations, and expanded its scientific team with four new hires. Jones takes up the permanent position from Vien Phan, who held the… Read More
Valneva presented its chikungunya vaccine candidate, VLA1553, on November 18 and 19, 2021 during the American Society of Tropical Medicine & Hygiene (ASTMH) 2021 Annual Meeting. Valneva’s Chief Medical Officer, Juan Carlos Jaramillo, presented: “Chikungunya: Phase III Clinical Development of a Single-shot Live-attenuated Vaccine” and Martina… Read More
In this free webinar, Dr. Christoph Herbel presents a newly developed workflow which combines flow cytometry–based screenings with high-parameter imaging to identify and validate new tumour markers in an unbiased approach. The event, Kill the tumour, spare the healthy tissue. Ultra high-content imaging enables target discovery for CAR T cell therapy, was hosted by DDW and supported by Miltenyi Biotec. It… Read More
News round-up by DDW’s Megan Thomas for 15-19 November As the world emerges from the Covid-19 pandemic, DDW’s Megan Thomas has rounded up five stories which show how the drug discovery industry has used what it has learnt over the last two years to innovate for the… Read More
Machine learning (ML) holds the promise to revolutionise drug discovery. By integrating vast datasets into predictive models, ML will help researchers arrive at the optimal candidate compounds more quickly, disrupting the long cycle times of preclinical discovery research. DEL technology is unmatched in its ability to produce ultra-large datasets. By… Read More
Lowering high blood pressure is an effective way to reduce a person’s risk of developing Type 2 diabetes in the future, according to research funded by the British Heart Foundation (BHF) and published in The Lancet. Doctors already prescribe blood pressure-lowering drugs to reduce a person’s chance… Read More
Sensitive signature peptide quantification using accurate mass spectrometry is a free webinar that was hosted by DDW on December 1, 2021, at 4PM GMT, 9AM PT; 12PM ET; 5PM CET. It was supported by SCIEX. Dr. Xin Zhang, Senior Application Scientist at SCIEX, presented… Read More
Inscopix, a brain mapping platform company developing neurotechnologies for improved disease treatments, displayed the latest product and research innovations around its miniature microscope-based neural circuitry technology at the 50th annual meeting of the Society for Neuroscience (SfN), which was held virtually November 8-11. Showcasing new technologies that enable… Read More
Emergex Vaccines has announced that it has received the necessary regulatory approvals to initiate a Phase I clinical trial to evaluate the safety and tolerability of its vaccine candidate for SARS-CoV-2. The Phase I trial is a double-blind, randomised and comparator-controlled study of two groups of 13 volunteers at high… Read More
Discover how Central and Eastern Europe (CEE) provides an attractive environment to conduct clinical studies of any phase while partnered with a local CRO. Research Professionals’ Managing Partner, György Barta (PharmD) discusses the many benefits of conducting clinical studies in CEE as well how Research Professionals, a leading CRO with… Read More
Discover how Central and Eastern Europe (CEE) provides an attractive environment to conduct clinical studies of any phase while partnered with a local CRO in this interview with Research Professionals’ Managing Partner, György Barta (DPharm). Barta discusses the many benefits of conducting clinical studies in CEE as… Read More
Listen to this article on the DDW Podcast: The workload in pharmacovigilance (PV) is soaring and as new vaccines and medications enter the market, it’s crucial to track adverse events (AE). As AE reports still have to be filed within 24 hours, Kathleen O’Brien of Amplexor Life Sciences lays out a blueprint for centralising global AE… Read More
After decades of research, the UK implemented a human papillomavirus (HPV) vaccine programme for teenage girls in 2008. Now, for the first time, a study has shown that the UK HPV vaccine programme works and will save lives, according to research funded by Cancer Research UK. The vaccine was shown to… Read More
Insightful Science, the software company enabling the cloud for scientific discovery, has completed the transaction to acquire LabArchives. LabArchives is a research data management application, serving 600,000 scientists in academic, non-profit and commercial organisations. It automates data capture, enhances collaboration, creates seamless workflows, and improves lab efficiency. Matt Dunie,… Read More
On November 16, 2021, AstraZeneca reported that two billion doses of the Covid-19 vaccine have been released for supply. Experts have commented on the news and explained how it has been possible to produce so much of the vaccine in less than a year, and the unprecedented strategy used… Read More
Listen to this article on the DDW Podcast: Dr Seth Lederman is a physician-scientist, entrepreneur, and CEO of Tonix Pharmaceuticals. He talks to Lu Rahman about Tonix Pharmaceuticals’ mission to research and manufacture small molecules and biologics for the treatment of CNS and immunological conditions. Since its formation in 2011, Tonix Pharmaceuticals has harnessed the power of clinical… Read More
